• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类拓扑异构酶I的非经典功能:全基因组及药理学分析

Nonclassic functions of human topoisomerase I: genome-wide and pharmacologic analyses.

作者信息

Miao Ze-Hong, Player Audrey, Shankavaram Uma, Wang Yong-Hong, Zimonjic Drazen B, Lorenzi Philip L, Liao Zhi-Yong, Liu Hong, Shimura Tsutomu, Zhang Hong-Liang, Meng Ling-Hua, Zhang Yong-Wei, Kawasaki Ernest S, Popescu Nicholas C, Aladjem Mirit I, Goldstein David J, Weinstein John N, Pommier Yves

机构信息

Laboratories of Molecular Pharmacology, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland, USA.

出版信息

Cancer Res. 2007 Sep 15;67(18):8752-61. doi: 10.1158/0008-5472.CAN-06-4554.

DOI:10.1158/0008-5472.CAN-06-4554
PMID:17875716
Abstract

The biological functions of nuclear topoisomerase I (Top1) have been difficult to study because knocking out TOP1 is lethal in metazoans. To reveal the functions of human Top1, we have generated stable Top1 small interfering RNA (siRNA) cell lines from colon and breast carcinomas (HCT116-siTop1 and MCF-7-siTop1, respectively). In those clones, Top1 is reduced approximately 5-fold and Top2alpha compensates for Top1 deficiency. A prominent feature of the siTop1 cells is genomic instability, with chromosomal aberrations and histone gamma-H2AX foci associated with replication defects. siTop1 cells also show rDNA and nucleolar alterations and increased nuclear volume. Genome-wide transcription profiling revealed 55 genes with consistent changes in siTop1 cells. Among them, asparagine synthetase (ASNS) expression was reduced in siTop1 cells and in cells with transient Top1 down-regulation. Conversely, Top1 complementation increased ASNS, indicating a causal link between Top1 and ASNS expression. Correspondingly, pharmacologic profiling showed L-asparaginase hypersensitivity in the siTop1 cells. Resistance to camptothecin, indenoisoquinoline, aphidicolin, hydroxyurea, and staurosporine and hypersensitivity to etoposide and actinomycin D show that Top1, in addition to being the target of camptothecins, also regulates DNA replication, rDNA stability, and apoptosis. Overall, our studies show the pleiotropic nature of human Top1 activities. In addition to its classic DNA nicking-closing functions, Top1 plays critical nonclassic roles in genomic stability, gene-specific transcription, and response to various anticancer agents. The reported cell lines and approaches described in this article provide new tools to perform detailed functional analyses related to Top1 function.

摘要

细胞核拓扑异构酶I(Top1)的生物学功能一直难以研究,因为敲除TOP1在多细胞动物中是致死的。为了揭示人类Top1的功能,我们分别从结肠癌和乳腺癌中构建了稳定的Top1小干扰RNA(siRNA)细胞系(分别为HCT116-siTop1和MCF-7-siTop1)。在这些克隆中,Top1减少了约5倍,Top2α补偿了Top1的缺陷。siTop1细胞的一个显著特征是基因组不稳定,伴有与复制缺陷相关的染色体畸变和组蛋白γ-H2AX焦点。siTop1细胞还表现出核糖体DNA(rDNA)和核仁改变以及核体积增加。全基因组转录谱分析显示,有55个基因在siTop1细胞中发生了一致的变化。其中,天冬酰胺合成酶(ASNS)在siTop1细胞和瞬时下调Top1的细胞中表达降低。相反,Top1互补增加了ASNS的表达,表明Top1与ASNS表达之间存在因果关系。相应地,药物敏感性分析显示siTop1细胞对L-天冬酰胺酶过敏。对喜树碱、茚并异喹啉、阿非迪霉素、羟基脲和星形孢菌素耐药,对依托泊苷和放线菌素D过敏,这表明Top1除了是喜树碱类药物的靶点外,还调节DNA复制、rDNA稳定性和细胞凋亡。总体而言,我们的研究表明人类Top1活性具有多效性。除了其经典的DNA切口-封闭功能外,Top1在基因组稳定性、基因特异性转录以及对各种抗癌药物的反应中发挥着关键的非经典作用。本文报道的细胞系和方法为进行与Top1功能相关的详细功能分析提供了新工具。

相似文献

1
Nonclassic functions of human topoisomerase I: genome-wide and pharmacologic analyses.人类拓扑异构酶I的非经典功能:全基因组及药理学分析
Cancer Res. 2007 Sep 15;67(18):8752-61. doi: 10.1158/0008-5472.CAN-06-4554.
2
Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.三种对SN-38耐药的人结肠癌细胞系中DNA拓扑异构酶I的特征分析揭示了一对新的耐药相关突变。
J Exp Clin Cancer Res. 2016 Mar 31;35:56. doi: 10.1186/s13046-016-0335-x.
3
Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells.泛素/26S蛋白酶体介导的拓扑异构酶I降解作为肿瘤细胞对喜树碱的耐药机制。
Cancer Res. 2001 Aug 1;61(15):5926-32.
4
New Topoisomerase I mutations are associated with resistance to camptothecin.新的拓扑异构酶 I 突变与喜树碱耐药性相关。
Mol Cancer. 2011 May 27;10:64. doi: 10.1186/1476-4598-10-64.
5
Proteasome-dependent processing of topoisomerase I-DNA adducts into DNA double strand breaks at arrested replication forks.蛋白酶体依赖性将拓扑异构酶I-DNA加合物加工成停滞复制叉处的DNA双链断裂。
J Biol Chem. 2009 Oct 9;284(41):28084-28092. doi: 10.1074/jbc.M109.030601. Epub 2009 Aug 6.
6
Genome-destabilizing effects associated with top1 loss or accumulation of top1 cleavage complexes in yeast.酵母中与拓扑异构酶1(Top1)缺失或Top1切割复合物积累相关的基因组不稳定效应。
PLoS Genet. 2015 Apr 1;11(4):e1005098. doi: 10.1371/journal.pgen.1005098. eCollection 2015 Apr.
7
Three missense mutations of DNA topoisomerase I in highly camptothecin-resistant colon cancer cell sublines.三种 DNA 拓扑异构酶 I 的错义突变与高度喜树碱耐药结肠癌细胞亚系相关。
Oncol Rep. 2013 Sep;30(3):1053-8. doi: 10.3892/or.2013.2594. Epub 2013 Jul 5.
8
Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors.通过拓扑异构酶 I 诱导的新型剪接变体的全基因组分析表明,剪接因子编码基因中优先发生。
Cancer Res. 2010 Oct 15;70(20):8055-65. doi: 10.1158/0008-5472.CAN-10-2491. Epub 2010 Sep 3.
9
Identification and characterization of a deletion mutant of DNA topoisomerase I mRNA in a camptothecin-resistant subline of human colon carcinoma.人结肠癌喜树碱耐药亚系中DNA拓扑异构酶I mRNA缺失突变体的鉴定与特征分析
Jpn J Cancer Res. 2000 May;91(5):551-9. doi: 10.1111/j.1349-7006.2000.tb00980.x.
10
DNA Topoisomerase I differentially modulates R-loops across the human genome.DNA 拓扑异构酶 I 差异调节人类基因组中的 R 环。
Genome Biol. 2018 Jul 30;19(1):100. doi: 10.1186/s13059-018-1478-1.

引用本文的文献

1
Current Role of Topoisomerase I Inhibitors for the Treatment of Mesenchymal Malignancies and Their Potential Future Use as Payload of Sarcoma-Specific Antibody-Drug Conjugates.拓扑异构酶I抑制剂在间充质恶性肿瘤治疗中的当前作用及其作为肉瘤特异性抗体药物偶联物有效载荷的潜在未来应用。
Oncol Res Treat. 2024;47(1-2):18-41. doi: 10.1159/000535491. Epub 2023 Nov 28.
2
R-loops, type I topoisomerases and cancer.R环、I型拓扑异构酶与癌症
NAR Cancer. 2023 Mar 3;5(1):zcad013. doi: 10.1093/narcan/zcad013. eCollection 2023 Mar.
3
Ago2 and a miRNA reduce Topoisomerase 1 for enhancing DNA cleavage in antibody diversification by activation-induced cytidine deaminase.
AGO2 和 microRNA 减少拓扑异构酶 1,通过激活诱导的胞苷脱氨酶增强抗体多样性中的 DNA 切割。
Proc Natl Acad Sci U S A. 2023 May 2;120(18):e2216918120. doi: 10.1073/pnas.2216918120. Epub 2023 Apr 24.
4
Survival-Associated Metabolic Genes and Risk Scoring System in HER2-Positive Breast Cancer.HER2 阳性乳腺癌中与生存相关的代谢基因和风险评分系统。
Front Endocrinol (Lausanne). 2022 May 19;13:813306. doi: 10.3389/fendo.2022.813306. eCollection 2022.
5
Human topoisomerases and their roles in genome stability and organization.人类拓扑异构酶及其在基因组稳定性和组织中的作用。
Nat Rev Mol Cell Biol. 2022 Jun;23(6):407-427. doi: 10.1038/s41580-022-00452-3. Epub 2022 Feb 28.
6
Machine Learning analysis of high-grade serous ovarian cancer proteomic dataset reveals novel candidate biomarkers.机器学习分析高级别浆液性卵巢癌蛋白质组数据集揭示新的候选生物标志物。
Sci Rep. 2022 Feb 23;12(1):3041. doi: 10.1038/s41598-022-06788-2.
7
Adaptive laboratory evolution in S. cerevisiae highlights role of transcription factors in fungal xenobiotic resistance.在酿酒酵母中的适应性实验室进化突出了转录因子在真菌外源化合物抗性中的作用。
Commun Biol. 2022 Feb 11;5(1):128. doi: 10.1038/s42003-022-03076-7.
8
MYC assembles and stimulates topoisomerases 1 and 2 in a "topoisome".MYC 在“拓扑异构酶体”中组装并刺激拓扑异构酶 1 和 2。
Mol Cell. 2022 Jan 6;82(1):140-158.e12. doi: 10.1016/j.molcel.2021.11.016. Epub 2021 Dec 9.
9
The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer.RNA 聚合酶 I 转录抑制剂 CX-5461 通过增强同源重组功能良好的高级别浆液性卵巢癌中的 DNA 损伤反应与拓扑异构酶 1 抑制协同作用。
Br J Cancer. 2021 Feb;124(3):616-627. doi: 10.1038/s41416-020-01158-z. Epub 2020 Nov 11.
10
Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.5-氨基乙基苯并菲啶酮衍生物的合成与生物评价作为 DNA 拓扑异构酶 IB 抑制剂。
Eur J Med Chem. 2019 Sep 15;178:81-92. doi: 10.1016/j.ejmech.2019.05.074. Epub 2019 May 30.